Skip to main content

Table 2 Percentage of patients who saw reduction in CRP or tumour marker levels after IVC therapy “ ± ” indicates 95% confidence intervals, “†” indicates proportions significantly above 50%

From: Effect of high-dose intravenous vitamin C on inflammation in cancer patients

Cancer Type N % Improvement  
CRP Reduction    
Prostate 14 79 ± 21
Breast 10 80 ± 25
All patients 45 76 ± 13
Tumour Marker Reduction    
Prostate 18 77 ± 21
All PSA 20 75 ± 19
Breast 11 73 ± 26  
All CA/CEA 19 53 ± 22  
All patients 40 65 ± 15